JP2002128763A - Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid - Google Patents

Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid

Info

Publication number
JP2002128763A
JP2002128763A JP2000328203A JP2000328203A JP2002128763A JP 2002128763 A JP2002128763 A JP 2002128763A JP 2000328203 A JP2000328203 A JP 2000328203A JP 2000328203 A JP2000328203 A JP 2000328203A JP 2002128763 A JP2002128763 A JP 2002128763A
Authority
JP
Japan
Prior art keywords
dialkylpyrazole
carboxylic acid
group
purifying
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000328203A
Other languages
Japanese (ja)
Inventor
Miki Enomoto
幹 榎本
Kenichi Sato
佐藤  賢一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP2000328203A priority Critical patent/JP2002128763A/en
Publication of JP2002128763A publication Critical patent/JP2002128763A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a method for isolating and purifying a 1,3-dialkylpyrazole-4- carboxylic acid from the isomer, a 1,5-dialkylpyrazole-4-carboxylic acid. SOLUTION: This method for isolating the 1,3-dialkylpyrazole-4-carboxylic acid is characterized by regulating an aqueous solution containing the 1,3- dialkylpyrazole-4-carboxylic acid represented by general formula (1) (wherein, R1 denotes a 1-10C chain or cyclic alkyl group; R2 denotes hydrogen atom, a halogen atom, a 1-10C alkyl group or a haloalkyl group) and the 1,5- dialkylpyrazole-4-carboxylic acid represented by general formula (2) (wherein, R1 and R2 denote each the same meaning as that described above) to pH 1.5-4.5 and crystallizing the 1,3-dialkylpyrazole-4-carboxylic acid.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は1,3−ジアルキル
ピラゾール−4−カルボン酸の新規な精製法に関する。
1,3−ジアルキルピラゾール−4−カルボン酸は医
薬、農薬等の中間体として有用である。
TECHNICAL FIELD The present invention relates to a novel method for purifying 1,3-dialkylpyrazole-4-carboxylic acid.
1,3-Dialkylpyrazole-4-carboxylic acid is useful as an intermediate for pharmaceuticals, agricultural chemicals and the like.

【0002】[0002]

【従来の技術】1,3−ジアルキルピラゾール−4−カ
ルボン酸の製造方法としては、β−ケト酸エステルを出
発原料として、ヒドラジン類との環化反応で1,3−ジ
アルキルピラゾール−4−カルボン酸エステルを製造し
(Aust.J.Chem.,36.135.1983)、更にそれをアルカリ加水
分解することによって得る方法(特公表 7-501549号公
報)が一般的に知られている。しかしこの製造法によっ
て製造された1,3−ジアルキルピラゾール−4−カル
ボン酸には、不純物として目的物の異性体で、主に環化
の際に生じる1,5−ジアルキルピラゾール−4−カル
ボン酸が含まれている。そしてその精製方法としては現
在シリカゲルカラムクロマトグラフィーによる精製が主
として知られているが、その操作は工業的に煩雑であ
り、大量の溶媒を使用するという問題点がある。
2. Description of the Related Art As a method for producing 1,3-dialkylpyrazole-4-carboxylic acid, a β-keto acid ester is used as a starting material and a 1,3-dialkylpyrazole-4-carboxylic acid is produced by a cyclization reaction with hydrazines. To produce acid esters
(Aust. J. Chem., 36.135.1983), and a method of further obtaining it by alkali hydrolysis (Japanese Patent Publication No. 7-501549) is generally known. However, the 1,3-dialkylpyrazole-4-carboxylic acid produced by this production method is an isomer of the target product as an impurity, and is mainly a 1,5-dialkylpyrazole-4-carboxylic acid produced during cyclization. It is included. As a purification method, purification by silica gel column chromatography is mainly known at present, but the operation is industrially complicated and there is a problem that a large amount of solvent is used.

【0003】[0003]

【発明が解決しようとする課題】前述のように、現在知
られている1,3−ジアルキルピラゾール−4−カルボ
ン酸の精製法は、工業的には不向きな方法である。そこ
で本発明の目的は、1,3−ジアルキルピラゾール−4
−カルボン酸の精製法として、主にその異性体である
1,5−ジアルキルピラゾール−4−カルボン酸との単
離法を提供することにある。
As described above, the currently known method for purifying 1,3-dialkylpyrazole-4-carboxylic acid is industrially unsuitable. Therefore, an object of the present invention is to provide 1,3-dialkylpyrazole-4.
Another object of the present invention is to provide a method for purifying a carboxylic acid, which is mainly an isomer thereof, which is isolated from 1,5-dialkylpyrazole-4-carboxylic acid.

【0004】[0004]

【課題を解決するための手段】本発明者らは1,3−ジ
アルキルピラゾール−4−カルボン酸の精製法を鋭意検
討した結果、水溶液中のpH管理による晶析法で精製す
ることにより、上記課題を解決可能であることを見出
し、更に工業的にも操作可能であることを見出し、本発
明を完成させた。
Means for Solving the Problems The inventors of the present invention have conducted intensive studies on a method for purifying 1,3-dialkylpyrazole-4-carboxylic acid. The inventors have found that the problem can be solved, and have found that they can be operated industrially, and have completed the present invention.

【0005】即ち、本発明は一般式(1)That is, the present invention provides a compound represented by the general formula (1):

【化3】 (式中、R1は炭素数1から10の鎖状または環状のア
ルキル基を示し、R2は水素原子、ハロゲン原子、炭素
数1から10のアルキル基、またはハロアルキル基を示
す。)で表される1,3−ジアルキルピラゾール−4−
カルボン酸と、一般式(2)
Embedded image (Wherein, R1 represents a chain or cyclic alkyl group having 1 to 10 carbon atoms, and R2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, or a haloalkyl group). 1,3-dialkylpyrazole-4-
Carboxylic acid and the general formula (2)

【0006】[0006]

【化4】 (式中、R1、R2は前記と同じ意味を示す。)で表され
る1,5−ジアルキルピラゾール−4−カルボン酸を含
む水溶液を、pH1.5〜pH4.5に調整して晶析す
ることを特徴とする1,3−ジアルキルピラゾール−4
−カルボン酸の精製法を提供するものである。
Embedded image (Wherein, R1 and R2 have the same meaning as described above), and the aqueous solution containing 1,5-dialkylpyrazole-4-carboxylic acid is adjusted to pH 1.5 to pH 4.5 and crystallized. 1,3-dialkylpyrazole-4 characterized by the following:
A method for purifying carboxylic acids.

【0007】[0007]

【発明の実施の形態】以下、本発明を詳細に説明する。
本発明に用いられる一般式(1)及び(2)の化合物に
おける置換基R1は、炭素数1から10の鎖状または環
状のアルキル基であり、その典型的な例としては、メチ
ル基、エチル基、n-プロピル基、イソプロピル基、n-ブ
チル基、イソブチル基、sec-ブチル基、t-ブチル基、n-
ペンチル基、n-ヘキシル基、n-ヘプチル基、n-オクチル
基、シクロアルキル基等が挙げられる。好ましくはメチ
ル基である。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
The substituent R1 in the compounds of the general formulas (1) and (2) used in the present invention is a linear or cyclic alkyl group having 1 to 10 carbon atoms, and typical examples thereof include a methyl group and an ethyl group. Group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, t-butyl group, n-
Examples include a pentyl group, n-hexyl group, n-heptyl group, n-octyl group, and cycloalkyl group. Preferably it is a methyl group.

【0008】本発明に用いられる一般式(1)及び
(2)の化合物における置換基R2は、水素原子、ハロ
ゲン原子、炭素数1から10のアルキル基、またはハロ
アルキル基であり、その典型的な例としては、フッ素原
子、塩素原子、臭素原子、メチル基、モノフルオロメチ
ル基、ジフルオロメチル基、トリフルオロメチル基、モ
ノクロロメチル基、ジクロロメチル基、トリクロロメチ
ル基、モノブロモメチル基、ジブロモメチル基、トリブ
ロモメチル基等が挙げられる。好ましくはトリフルオロ
メチル基である。
The substituent R2 in the compounds of the general formulas (1) and (2) used in the present invention is a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, or a haloalkyl group. Examples include fluorine, chlorine, bromine, methyl, monofluoromethyl, difluoromethyl, trifluoromethyl, monochloromethyl, dichloromethyl, trichloromethyl, monobromomethyl, dibromomethyl And a tribromomethyl group. Preferably it is a trifluoromethyl group.

【0009】晶析時の温度は好ましくは5〜95℃であ
り、更に好ましくは15〜25℃である。晶析時間は一
般的に30分乃至7日間であるが、好ましくは1乃至2
4時間である。
The temperature at the time of crystallization is preferably from 5 to 95 ° C, more preferably from 15 to 25 ° C. The crystallization time is generally from 30 minutes to 7 days, preferably from 1 to 2 days.
4 hours.

【0010】晶析方法は、一例を挙げると、まず1,3
−ジアルキルピラゾール−4−カルボン酸と、1,5−
ジアルキルピラゾール−4−カルボン酸の混合粗結晶を
溶解させるために、一旦水溶液をpH6以上に調整す
る。pHの調整には、例えば水酸化ナトリウム、水酸化
カリウム等を使用し、精製する1,3−ジアルキルピラ
ゾール−4−カルボン酸と、1,5−ジアルキルピラゾ
ール−4−カルボン酸の約1.1当量分を蒸留水に溶解
する。
The crystallization method is, for example, first, 1, 3
-Dialkylpyrazole-4-carboxylic acid and 1,5-
The aqueous solution is once adjusted to pH 6 or higher to dissolve the mixed crude crystals of dialkylpyrazole-4-carboxylic acid. To adjust the pH, for example, sodium hydroxide, potassium hydroxide, or the like is used, and the purified 1,3-dialkylpyrazole-4-carboxylic acid and about 1,1-dialkylpyrazole-4-carboxylic acid of about 1.1 Dissolve an equivalent amount in distilled water.

【0011】その後に、35%塩酸により晶析マスのp
Hを下げながら晶析させる。その際のpH値について
は、1,3−ジアルキルピラゾール−4−カルボン酸の
晶析収率を上げるために、pH4.5より低いpH値で
あることが望ましい。しかしここで、除去させる1,5
−ジアルキルピラゾール−4−カルボン酸が、晶析し始
めるpH3.0以上に好ましくは調節することによっ
て、目的の1,3−ジアルキルピラゾール−4−カルボ
ン酸を精製することができる。
Then, the p of the crystallization mass is added with 35% hydrochloric acid.
Crystallize while lowering H. The pH value at that time is desirably a pH value lower than 4.5 to increase the crystallization yield of 1,3-dialkylpyrazole-4-carboxylic acid. But here, 1,5
The target 1,3-dialkylpyrazole-4-carboxylic acid can be purified by preferably adjusting the pH of the -dialkylpyrazole-4-carboxylic acid to start to crystallize to 3.0 or more.

【0012】晶析時のpH調整に使用する試薬として
は、塩酸、硫酸等が挙げられるが、好ましくは塩酸であ
る。使用する塩酸の濃度は、いずれの濃度でも問題ない
が、好ましくは1〜35.5%であり、更に好ましくは
35.5%のものである。硫酸を使用する場合の濃度も
特に限定はないが、好ましくは1〜98%であり、更に
好ましくは98%のものである。濃度の高いものの方が
好ましい。
As a reagent used for pH adjustment during crystallization, hydrochloric acid, sulfuric acid and the like can be mentioned, but hydrochloric acid is preferred. There is no problem with the concentration of the hydrochloric acid used, but it is preferably 1 to 5.5%, and more preferably 35.5%. The concentration when sulfuric acid is used is not particularly limited, but is preferably 1 to 98%, and more preferably 98%. Higher concentrations are preferred.

【0013】晶析時のpH値は1.5〜4.5であり、
好ましくは2.5〜4.0、更に好ましくは3.0〜
3.5である。
The pH value during crystallization is 1.5 to 4.5,
Preferably 2.5-4.0, more preferably 3.0-4.0.
3.5.

【0014】精製後の目的物の取り出しについては、通
常の方法で実施可能であり、例えば晶析後にろ過、及び
洗浄することで目的の結晶が得られる。
The target product after purification can be taken out by a usual method. For example, the target crystal can be obtained by filtering and washing after crystallization.

【0015】[0015]

【実施例】以下に実施例を挙げて本発明の内容を具体的
に説明する。 参考例 2−エトキシメチリデン−3−オキソ−4,4,4−ト
リフルオロブタン酸エチルエステル 26g(0.11mol)を酢
酸エチル100gに溶解し、0℃条件下でモノメチルヒドラ
ジン 5g(0.11mol)を滴下し、4時間反応させた。その後
85gの希塩酸と水で洗浄後濃縮して29.2gのオイル成分
を得、このオイル成分に含まれる1−メチル−3−トリ
フルオロメチルピラゾール−4−カルボン酸エチルは2
0.2g(0.09mol、収率83.9%)であった。
EXAMPLES The contents of the present invention will be specifically described below with reference to examples. Reference Example 2-Ethoxymethylidene-3-oxo-4,4,4-trifluorobutanoic acid ethyl ester (26 g, 0.11 mol) was dissolved in ethyl acetate (100 g), and monomethylhydrazine (5 g, 0.11 mol) was added at 0 ° C. The mixture was dropped and reacted for 4 hours. Thereafter, the mixture was washed with 85 g of dilute hydrochloric acid and water and then concentrated to obtain 29.2 g of an oil component. The oil component contained ethyl 1-methyl-3-trifluoromethylpyrazole-4-carboxylate as 2
The amount was 0.2 g (0.09 mol, yield: 83.9%).

【0016】m.p. 62.6〜63.7℃1 H-NMR(CDCl3/TMS;δppm):1.35(3H,t,J=7.0Hz),3.97(3
H,s),4.30(2H,q,J=7.0Hz),7.95(1H,s) 異性体1−メチル−5−トリフルオロメチルピラゾール
−4−カルボン酸エチルは3.7g(0.02mol、収率15.2%)で
あり、異性対比は18.3%であった。
Mp 62.6-63.7 ° C. 1 H-NMR (CDCl 3 / TMS; δ ppm): 1.35 (3 H, t, J = 7.0 Hz), 3.97 (3
H, s), 4.30 (2H, q, J = 7.0 Hz), 7.95 (1H, s) 3.7 g (0.02 mol, yield) of ethyl isomer 1-methyl-5-trifluoromethylpyrazole-4-carboxylate 15.2%), and the isomer ratio was 18.3%.

【0017】1H-NMR(CDCl3;δppm):1.35(3H,t J=7.3H
z),4.07(3H,q,J=2.0Hz),4.33(3H,q,J=7.3Hz),7.91(1H,
s)
1 H-NMR (CDCl 3; δ ppm): 1.35 (3 H, t J = 7.3 H
z), 4.07 (3H, q, J = 2.0Hz), 4.33 (3H, q, J = 7.3Hz), 7.91 (1H,
s)

【0018】実施例1 1−メチル−3−トリフルオロメチルピラゾール−4−
カルボン酸エチル20.2g(0.09mol)、その異性体1−メチ
ル−5−トリフルオロメチルピラゾール−4−カルボン
酸エチルが3.7g(0.02mol)含まれた(異性対比1
8.3%)オイル成分29.2gを、15%苛性水50gに溶
解し、60℃に昇温し、60℃で1時間熟成した。この
熟成後の反応マス中、1−メチル−5−トリフルオロメ
チルピラゾール−4−カルボン酸の1−メチル−3−ト
リフルオロメチルピラゾール−4−カルボン酸に対する
異性対比は14.2%であった。その後135gの水で反応マス
を希釈した後、35.5%塩酸を滴下し、pH値3.0に調整し、
20℃で1時間晶析、ろ過することで白色結晶を得た。
その場合の結晶中の異性体比及び、晶析収率はそれぞれ
0.3%、96.3%であった。
Example 1 1-methyl-3-trifluoromethylpyrazole-4-
It contained 20.2 g (0.09 mol) of ethyl carboxylate and 3.7 g (0.02 mol) of its isomer ethyl 1-methyl-5-trifluoromethylpyrazole-4-carboxylate (1 isomer ratio).
(8.3%) 29.2 g of an oil component was dissolved in 50 g of 15% caustic water, heated to 60 ° C., and aged at 60 ° C. for 1 hour. In the reaction mass after this aging, the isomer ratio of 1-methyl-5-trifluoromethylpyrazole-4-carboxylic acid to 1-methyl-3-trifluoromethylpyrazole-4-carboxylic acid was 14.2%. After diluting the reaction mass with 135 g of water, 35.5% hydrochloric acid was added dropwise to adjust the pH value to 3.0,
Crystallization at 20 ° C. for 1 hour and filtration yielded white crystals.
In that case, the isomer ratio in the crystal and the crystallization yield are respectively
0.3% and 96.3%.

【0019】1−メチル−3−トリフルオロメチルピラ
ゾール−4−カルボン酸 m.p. 201〜203℃1 H-NMR(CDCl3;δppm):3.97(3H,s),8.01(1H,s) 1−メチル−5−トリフルオロメチルピラゾール−4−
カルボン酸1 H-NMR(DMSO;δppm):4.03(3h,q,J=2.0Hz),7.95(1H,s) m.p. 200〜201℃
1-methyl-3-trifluoromethylpyrazole-4-carboxylic acid mp 201-203 ° C. 1 H-NMR (CDCl3; δ ppm): 3.97 (3H, s), 8.01 (1H, s) 1-methyl- 5-trifluoromethylpyrazole-4-
Carboxylic acid 1 H-NMR (DMSO; δ ppm): 4.03 (3 h, q, J = 2.0 Hz), 7.95 (1 H, s) mp 200-201 ° C.

【0020】実施例2 異性体である1−メチル−5−トリフルオロメチルピラ
ゾール−4−カルボン酸が、約10.57%の割合で含まれて
いる1−メチル−3−トリフルオロメチルピラゾール−
4−カルボン酸の混合粗結晶10gを、水100gにN
aOH2.4gを溶解させたアルカリ溶液に溶解させ
た。そしてそこに塩酸を滴下し各pH値に調整し、20
℃で1時間晶析、ろ過することで各種白色結晶を得た。
それらの分析結果から、各pH値で得られた結晶中の異性
対比及び、1−メチル−3−トリフルオロメチルピラゾ
ール−4−カルボン酸の晶析収率は以下の表1に示すよ
うになった。
Example 2 1-methyl-3-trifluoromethylpyrazole containing the isomer 1-methyl-5-trifluoromethylpyrazole-4-carboxylic acid in a proportion of about 10.57%
10 g of the mixed crude crystals of 4-carboxylic acid was added to 100 g of water with N
The solution was dissolved in an alkaline solution in which 2.4 g of aOH was dissolved. Then, hydrochloric acid was added dropwise to the mixture to adjust each pH value.
Crystallization at 1 ° C. for 1 hour and filtration yielded various white crystals.
From the analysis results, the isomer ratio in the crystals obtained at each pH value and the crystallization yield of 1-methyl-3-trifluoromethylpyrazole-4-carboxylic acid are as shown in Table 1 below. Was.

【0021】[0021]

【表1】 [Table 1]

【0022】[0022]

【発明の効果】以上で述べたように、本発明によれば、
医薬、農薬等の中間体として有用な1,3−ジアルキル
ピラゾール−4−カルボン酸を効率よく精製することが
可能であり、工業的に優れているものである。
As described above, according to the present invention,
It is possible to efficiently purify 1,3-dialkylpyrazole-4-carboxylic acid, which is useful as an intermediate for pharmaceuticals, agricultural chemicals, etc., and it is industrially excellent.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】一般式(1) 【化1】 (式中、R1は炭素数1から10の鎖状または環状のア
ルキル基を示し、R2は水素原子、ハロゲン原子、炭素
数1から10のアルキル基、またはハロアルキル基を示
す。)で表される1,3−ジアルキルピラゾール−4−
カルボン酸と、一般式(2) 【化2】 (式中、R1、R2は前記と同じ意味を示す。)で表され
る1,5−ジアルキルピラゾール−4−カルボン酸を含
む水溶液を、pH1.5〜pH4.5に調整して晶析す
ることを特徴とする1,3−ジアルキルピラゾール−4
−カルボン酸の精製法。
1. A compound of the general formula (1) (Wherein, R1 represents a chain or cyclic alkyl group having 1 to 10 carbon atoms, and R2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, or a haloalkyl group). 1,3-dialkylpyrazole-4-
A carboxylic acid and a compound represented by the general formula (2): (Wherein, R1 and R2 have the same meaning as described above), and the aqueous solution containing 1,5-dialkylpyrazole-4-carboxylic acid is adjusted to pH 1.5 to pH 4.5 and crystallized. 1,3-dialkylpyrazole-4 characterized by the following:
A method for purifying carboxylic acids.
【請求項2】 水溶液のpHが2.5〜4.0である請
求項1記載の方法。
2. The method according to claim 1, wherein the pH of the aqueous solution is 2.5 to 4.0.
【請求項3】 水溶液のpHが3.0〜3.5である請
求項1記載の方法。
3. The method according to claim 1, wherein the pH of the aqueous solution is 3.0 to 3.5.
【請求項4】 一般式(1)において、R1がメチル基、
R2がトリフルオロメチル基である請求項1〜3記載の
方法。
4. In the general formula (1), R1 is a methyl group,
4. The method according to claim 1, wherein R2 is a trifluoromethyl group.
JP2000328203A 2000-10-27 2000-10-27 Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid Pending JP2002128763A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000328203A JP2002128763A (en) 2000-10-27 2000-10-27 Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000328203A JP2002128763A (en) 2000-10-27 2000-10-27 Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid

Publications (1)

Publication Number Publication Date
JP2002128763A true JP2002128763A (en) 2002-05-09

Family

ID=18805090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000328203A Pending JP2002128763A (en) 2000-10-27 2000-10-27 Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid

Country Status (1)

Country Link
JP (1) JP2002128763A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103975A1 (en) 2003-05-21 2004-12-02 Bayer Cropscience Aktiengesellschaft Iodopyrazolyl carboxanilides
WO2008102678A1 (en) * 2007-02-20 2008-08-28 Mitsui Chemicals, Inc. Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
EP1997808A1 (en) * 2007-05-31 2008-12-03 Syngeta Participations AG Process for the production of pyrazoles
WO2008145257A1 (en) * 2007-05-31 2008-12-04 Syngenta Participations Ag Process for the production of pyrazoles
CN101133031B (en) * 2005-02-25 2010-07-21 财团法人相模中央化学研究所 Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
JP2013006780A (en) * 2011-06-22 2013-01-10 Central Glass Co Ltd Method for producing pyrazole compound

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103975A1 (en) 2003-05-21 2004-12-02 Bayer Cropscience Aktiengesellschaft Iodopyrazolyl carboxanilides
US7906656B2 (en) 2003-05-21 2011-03-15 Bayer Cropscience Ag Iodopyrazolyl carboxanilides
US8119682B2 (en) 2003-05-21 2012-02-21 Bayer Cropscience Ag Iodopyrazolyl carboxanilides
CN101133031B (en) * 2005-02-25 2010-07-21 财团法人相模中央化学研究所 Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
WO2008102678A1 (en) * 2007-02-20 2008-08-28 Mitsui Chemicals, Inc. Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
US7884216B2 (en) 2007-02-20 2011-02-08 Mitsui Chemicals Agro, Inc. Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
CN101627015B (en) * 2007-02-20 2012-02-29 三井化学Agro株式会社 Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarb and preparation method thereof
JP5117485B2 (en) * 2007-02-20 2013-01-16 三井化学アグロ株式会社 Fluorine-containing pyrazole carbonitrile derivative and method for producing the same, and fluorine-containing pyrazole carboxylic acid derivative obtained using the fluorine-containing pyrazole carbonitrile derivative and a method for producing the same.
EP1997808A1 (en) * 2007-05-31 2008-12-03 Syngeta Participations AG Process for the production of pyrazoles
WO2008145257A1 (en) * 2007-05-31 2008-12-04 Syngenta Participations Ag Process for the production of pyrazoles
US8124787B2 (en) 2007-05-31 2012-02-28 Syngenta Crop Protection, Inc. Process for the production of pyrazoles
JP2013006780A (en) * 2011-06-22 2013-01-10 Central Glass Co Ltd Method for producing pyrazole compound

Similar Documents

Publication Publication Date Title
JPH07215921A (en) Production of pest control agent and intermediate
JP2002128763A (en) Method for purifying 1,3-dialkylpyrazole-4-carboxylic acid
JP3743823B2 (en) Penicillin crystals and production method thereof
JP3440129B2 (en) Method for producing glutamine derivative
US20030181731A1 (en) Process for producing 5-fluorooxyindole and for producing intermediates therefor
JP2598703B2 (en) Method for producing butyl 3 '-(1H-tetrazol-5-yl) oxanilate
EP1288215B1 (en) Production method of famciclovir and production and crystallization method of intermediate therefor
JP5463051B2 (en) Method for producing 1,4-dihydropyridine derivative
JP2006522757A (en) Method for preparing 9-cis retinoic acid
KR101605185B1 (en) Preparation method of 2-(2-phthlimidoethoxy) acetic acid
JP2787973B2 (en) Purification method of piperidine intermediate
JP2842591B2 (en) Method for producing 4-hydroxycoumarin
JP7291782B2 (en) Synthetic methods for the preparation of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazole compounds
JP3823385B2 (en) Process for producing 2,4,5-trifluoro-3-iodobenzoic acid and esters thereof
JP2847672B2 (en) Method for producing 4-hydroxycoumarin
JP2006298872A (en) Manufacturing method of 1-fluoro-1-phenylthioethene
KR100413172B1 (en) A process for the preparation of quinolinone derivatives
JP2003160560A (en) Method for producing trans-4-substituted piperidine-2- carboxylate
JP2022502413A (en) Synthetic method for the preparation of alkoxymethylene-benzoylacetonitrile
JP5071689B2 (en) 3-alkoxycarbonyl-6,7-chloromethylenedioxycoumarin compound and method for producing the same.
JPH0446175A (en) Production of 5-hydroxy-3,4-methylenedioxybenzoic acid derivative
JP2005145960A (en) Method for preparing phenylacetic acid derivative
KR900001081B1 (en) A preparation process for 4-acyl-5-pyrazolyl 4-toluene sulfonate derivatives
JP4483183B2 (en) Process for producing 6,7-dihydroxycoumarin-3-carboxylic acid derivative and its intermediate
JP3221151B2 (en) Method for producing pyrrole derivatives